Table 1.
LTC effects on WBV, Hct, and AI.
| Groups | WBV (mPa·s) (n = 5) | Hct (%) (n = 6–8) | AI (n = 5) | ||
|---|---|---|---|---|---|
| 200 s−1 | 50 s−1 | 1 s−1 | |||
| HG | 3.99 ± 0.15 | 5.92 ± 0.314 | 31.32 ± 1.58 | 53.11 ± 1.77 | 8.02 ± 0.56 |
| LTC100 | 2.93 ± 0.22∗ | 4.56 ± 0.50 | 27.06 ± 2.89 | 52.91 ± 1.84 | 9.48 ± 0.85 |
| LTC200 | 2.70 ± 0.15∗ | 4.95 ± 0.60 | 26.78 ± 1.74 | 50.39 ± 4.48 | 9.35 ± 1.00 |
| LTC300 | 2.66 ± 0.19∗ | 4.72 ± 0.28 | 28.32 ± 1.87 | 48.78 ± 3.06 | 8.57 ± 0.68 |
| EG | 2.41 ± 0.18∗ | 3.84 ± 0.26∗ | 21.82 ± 1.19∗ | 55.41 ± 3.66 | 8.06 ± 0.31 |
Data are the mean ± SEM. ∗ P < 0.05 versus HG. AI: erythrocyte aggregation index, EG: ezetimibe-treated group, Hct: hematocrit, HFD: high fat diet, HG: HFD-induced group, LTC: Longxuetongluo Capsule, LTC100 group: low dose LTC-treated group, LTC200 group: middle dose LTC-treated group, LTC300 group: high dose LTC-treated group, and WBV: whole blood viscosity.